Stephen MacMahon AO's Publications

About Stephen MacMahon AO's Publications

Founding Director, The George Institute for Global Health
  • Professor of Cardiovascular Medicine, Faculty of Medicine, UNSW Sydney
  • Chair of Global Health, Faculty of Medicine, Imperial College of London

  • Two decades of research on innovative models of care delivery for patients with heart failure: the end or just the beginning?

    Archives of Iranian Medicine Date published:

  • Hematoma growth and outcomes in intracerebral hemorrhage: The INTERACT1 study

    Neurology Date published:

  • Effects of Blood Pressure Lowering on Intracranial and Extracranial Bleeding in Patients on Antithrombotic Therapy

    Stroke Date published:

  • O55 Gènes communs à plusieurs complications du Diabète de Type 2

    Diabetes & Metabolism Date published:

  • The Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS)

    Journal of the American College of Cardiology Date published:

  • Lack of Effect of Lowering LDL Cholesterol on Cancer: Meta-Analysis of Individual Data from 175,000 People in 27 Randomised Trials of Statin Therapy

    PLOS ONE Date published:

  • Visit-to-visit Variability of Systolic Blood Pressure Predicts Macrovascular and Microvascular Events in Patients with Type 2 Diabetes: the ADVANCE Trial

    International Journal of Stroke Date published:

  • Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds

    Diabetologia Date published:

  • Statins and Intracerebral Hemorrhage

    Circulation Date published:

  • Effects of Blood Pressure Lowering on Major Vascular Events Among Patients With Isolated Diastolic Hypertension

    Stroke Date published:

  • Effects of perindopril-indapamide on left ventricular diastolic function and mass in patients with type 2 diabetes: the ADVANCE Echocardiography Substudy

    Journal of Hypertension Date published:

  • Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts

    Kidney International Date published:

  • Cuts to the NHMRC budget will undermine the health of all Australians - today and in the future

    Medical Journal of Australia Date published:

  • A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals

    Journal of Hypertension Date published:

  • Intensive glucose lowering and end stage kidney disease: new data from the ADVANCE trial

    Date published:

  • EFFECTS OF BLOOD PRESSURE LOWERING ON INTRACRANIAL AND EXTRACRANIAL BLEEDING ASSOCIATED WITH ANTITHROMBOTIC THERAPY: THE PROGRESS TRIAL

    Date published: